AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25440795 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet function monitoring with dose and drug adjustment (Prasugrel 5 mg)
Number of subjects: 852
Study 25440795 — intervention group
Group type: COMPARATOR
Intervention: Conventional Treatment Arm (Prasugrel 5 mg without monitoring and adjustment)
Number of subjects: 852
Study 22805468 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (280 mg DHA and 110 mg EPA daily)
Number of subjects: 420
Study 22805468 — intervention group
Group type: COMPARATOR
Intervention: Control oil
Number of subjects: 420
Study 21187503 — intervention group
Group type: EXPERIMENTAL
Intervention: IT+MGN-3 (38 patients)
Number of subjects: 68
Study 21187503 — intervention group
Group type: COMPARATOR
Intervention: IT (30 patients)
Number of subjects: 68
Study 18270233 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-induced wrinkling
Number of subjects: 21
Study 18270233 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA-induced wrinkling
Number of subjects: 21
Study 18270233 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraepidermal nerve fibre density (IENFD)
Number of subjects: 21
Study 18270233 — intervention group
Group type: EXPERIMENTAL
Intervention: Sympathetic skin response (SSR)
Number of subjects: 21
Study 15686572 — intervention group
Group type: EXPERIMENTAL
Intervention: Gesture conveying a different strategy than speech
Number of subjects: 160
Study 15686572 — intervention group
Group type: EXPERIMENTAL
Intervention: Two problem-solving strategies taught in gesture
Number of subjects: 160
Study 15686572 — intervention group
Group type: COMPARATOR
Intervention: Gesture conveying the same strategy as speech
Number of subjects: 160
Study 14682412 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate DPI 250 microg b.i.d.
Number of subjects: 48
Study 14682412 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 10776899 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous hypoxia
Number of subjects: 10
Study 10776899 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia
Number of subjects: 10
Study 10776899 — intervention group
Group type: EXPERIMENTAL
Intervention: Both continuous and intermittent hypoxia
Number of subjects: 10
Study 8640993 — intervention group
Group type: EXPERIMENTAL
Intervention: MR cine GE images
Number of subjects: 47
Study 8640993 — intervention group
Group type: COMPARATOR
Intervention: Standard MR SE images
Number of subjects: 47
Study 8640993 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined analysis of SE and GE images
Number of subjects: 47
Study 8640993 — intervention group
Group type: EXPERIMENTAL
Intervention: MR phase velocity imaging
Number of subjects: 47
Study 8640993 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential grafts
Number of subjects: 47
Study 8261256 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 2890501 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin plus glyburide (IG)
Number of subjects: 20
Study 2890501 — intervention group
Group type: COMPARATOR
Intervention: Insulin plus placebo (IP)
Number of subjects: 20
Study 31801787 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 2536
Study 29390162 — intervention group
Group type: EXPERIMENTAL
Intervention: Androstadienone
Number of subjects: 30
Study 29390162 — intervention group
Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 30
Study 28265777 — intervention group
Group type: EXPERIMENTAL
Intervention: ISB + ICG (n = 180)
Number of subjects: 200
Study 28265777 — intervention group
Group type: COMPARATOR
Intervention: ISB (n = 20)
Number of subjects: 200
Study 26509769 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbomer-based lipid-containing artificial tear formulations (CBLAT) in the add-on group
Number of subjects: 412
Study 26509769 — intervention group
Group type: COMPARATOR
Intervention: Carbomer-based lipid-containing artificial tear formulations (CBLAT) in the switching group
Number of subjects: 412
Study 23194385 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (sustained nurse home visiting)
Number of subjects: 208
Study 23194385 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 208
Study 21508278 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly cross‐linked polyethylene
Number of subjects: 54
Study 21508278 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultra‐high molecular weight polyethylene
Number of subjects: 54
Study 19788662 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.2 mm incision
Number of subjects: 83
Study 19788662 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.6 mm incision
Number of subjects: 83
Study 19788662 — intervention group
Group type: COMPARATOR
Intervention: 3.0 mm incision
Number of subjects: 83
Study 16449487 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation antidepressants adjunctive to mood stabilizers
Number of subjects: 184
Study 16449487 — intervention group
Group type: COMPARATOR
Intervention: Mood stabilizers
Number of subjects: 184
Study 15310534 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination hormone therapy (conjugated equine estrogen, 0.625 mg, and medroxyprogesterone, 2.5 mg)
Number of subjects: 60
Study 15310534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 11273921 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sensory stimulation group (LSSG) with dimmed OR lights (200 Lx) and soft background music (Bach's 'Air on a G String', 50‐60 dB)
Number of subjects: 70
Study 11273921 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard operating conditions)
Number of subjects: 70
Study 8813502 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrograde laparoscopic cholecystectomy (RLC)
Number of subjects: 173
Study 8813502 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy
Number of subjects: 173
Study 1864667 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenalterol (35 micrograms/kg for 3 min)
Number of subjects: 21
Study 1864667 — intervention group
Group type: COMPARATOR
Intervention: K-strophanthidin (0.008 mg/kg for 5-10 min)
Number of subjects: 21
Study 6843182 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 0
Study 31833801 — intervention group
Group type: EXPERIMENTAL
Intervention: SAR341402 (SAR-Asp)
Number of subjects: 45
Study 31833801 — intervention group
Group type: COMPARATOR
Intervention: Originator insulin aspart (NN-Asp)
Number of subjects: 45
Study 30565797 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal role training program based on Mercer's Maternal Role Attainment Theory
Number of subjects: 67
Study 30565797 — intervention group
Group type: COMPARATOR
Intervention: Routine pregnancy care (Control)
Number of subjects: 67
Study 27684440 — intervention group
Group type: EXPERIMENTAL
Intervention: ADT + metformin
Number of subjects: 62
Study 27684440 — intervention group
Group type: COMPARATOR
Intervention: ADT
Number of subjects: 62
Study 26308457 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Psychological Intervention (IPI), including psychoeducation
Number of subjects: 128
Study 26308457 — intervention group
Group type: COMPARATOR
Intervention: Supportive Counselling (SC)
Number of subjects: 128
Study 26308457 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Psychological Intervention (IPI)
Number of subjects: 128
Study 22752014 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative CISC instructional video
Number of subjects: 199
Study 22752014 — intervention group
Group type: COMPARATOR
Intervention: Routine counseling
Number of subjects: 199
Study 22059392 — intervention group
Group type: EXPERIMENTAL
Intervention: EMA-14 (Esomeprazole 20 mg b.i.d., Moxifloxacin 400 mg o.d., Amoxicillin 1000 mg b.i.d. for 14 days)
Number of subjects: 80
Study 22059392 — intervention group
Group type: COMPARATOR
Intervention: EMA-7 (Esomeprazole 20 mg b.i.d., Moxifloxacin 400 mg o.d., Amoxicillin 1000 mg b.i.d. for 7 days)
Number of subjects: 80
Study 22059392 — intervention group
Group type: EXPERIMENTAL
Intervention: EMA-14
Number of subjects: 80
Study 22059392 — intervention group
Group type: COMPARATOR
Intervention: EMA-7
Number of subjects: 80
Study 18761778 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed oil (2.2 g total fatty acids/d)
Number of subjects: 0
Study 18761778 — intervention group
Group type: EXPERIMENTAL
Intervention: Borage oil (2.2 g total fatty acids/d)
Number of subjects: 0
Study 18761778 — intervention group
Group type: COMPARATOR
Intervention: Placebo (medium-chain fatty acids)
Number of subjects: 0
Study 17936003 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air warmers
Number of subjects: 15
Study 17936003 — intervention group
Group type: COMPARATOR
Intervention: Passive insulation
Number of subjects: 15
Study 15536429 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 195
Study 15536429 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 195
Study 11303197 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hormone replacement therapy
Number of subjects: 82
Study 11303197 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal hormone replacement therapy
Number of subjects: 82
Study 9121942 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet intervention, reducing percentage of calories from fat to 21% by Month 4 and maintaining that level for the remainder of the two-year study.
Number of subjects: 0
Study 9121942 — intervention group
Group type: EXPERIMENTAL
Intervention: Practical dietary advice on fat reduction and increased intake of grains, fruits, and vegetables.
Number of subjects: 0
Study 8126815 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral terbutaline
Number of subjects: 24
Study 8126815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 2607128 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 89
Study 2607128 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 89
Study 2607128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 4441859 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body hyperthermia alone (38 cases)
Number of subjects: 51
Study 4441859 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body hyperthermia in combination with chemotherapy (13 cases)
Number of subjects: 51
Study 31465585 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethylfumarate (DMF) 720 mg daily
Number of subjects: 671
Study 31465585 — intervention group
Group type: EXPERIMENTAL
Intervention: Fumaric acid esters (FAE)
Number of subjects: 671
Study 31465585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 671
Study 31465585 — intervention group
Group type: EXPERIMENTAL
Intervention: DMF and FAE (Week 8 PASI 50/75 responders)
Number of subjects: 671
Study 31465585 — intervention group
Group type: EXPERIMENTAL
Intervention: DMF and FAE (Week 8 PASI ≤ 3 and/or PGA 0-1 responders)
Number of subjects: 671
Study 31242890 — intervention group
Group type: EXPERIMENTAL
Intervention: Expenditure-specific warning messages
Number of subjects: 45
Study 31242890 — intervention group
Group type: COMPARATOR
Intervention: Generic warning messages
Number of subjects: 45
Study 31242890 — intervention group
Group type: COMPARATOR
Intervention: Control messages
Number of subjects: 45
Study 26951578 — intervention group
Group type: EXPERIMENTAL
Intervention: TC with music (TC + M)
Number of subjects: 18
Study 26951578 — intervention group
Group type: COMPARATOR
Intervention: TC in silence (TC + S)
Number of subjects: 18
Study 26334856 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of methylprednisolone intravenously before CPB
Number of subjects: 40
Study 26334856 — intervention group
Group type: COMPARATOR
Intervention: Standard CABG surgery without any additional medication (Control)
Number of subjects: 40
Study 23456585 — intervention group
Group type: EXPERIMENTAL
Intervention: Education based on the Health Belief Model (HBM)
Number of subjects: 180
Study 23456585 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 180
Study 22408581 — intervention group
Group type: EXPERIMENTAL
Intervention: High calorie, low nutrient (HCLN) intake
Number of subjects: 964
Study 22408581 — intervention group
Group type: EXPERIMENTAL
Intervention: Video gaming behaviors
Number of subjects: 964
Study 22408581 — intervention group
Group type: EXPERIMENTAL
Intervention: HCLN intake
Number of subjects: 964
Study 19225268 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg/day) for 2 months
Number of subjects: 22
Study 19225268 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 2 months
Number of subjects: 22
Study 16859690 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotionally expressive coping
Number of subjects: 342
Study 16859690 — intervention group
Group type: COMPARATOR
Intervention: None (control group)
Number of subjects: 342
Study 12722963 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct clinician-to-patient feedback discussion on inhaled steroid and beta-agonist use
Number of subjects: 19
Study 12722963 — intervention group
Group type: COMPARATOR
Intervention: Standard asthma care (Control)
Number of subjects: 19
Study 12722963 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct clinician-to-patient feedback discussion
Number of subjects: 19
Study 12722963 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study 10836281 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride (200-800 mg/day)
Number of subjects: 488
Study 10836281 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (5-20 mg/day)
Number of subjects: 488
Study 10836281 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 488
Study 10836281 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 488
Study 9337629 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on means-ends behaviors
Number of subjects: 1
Study 9337629 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 1
Study 8409060 — intervention group
Group type: EXPERIMENTAL
Intervention: Albunex 0.08 ml/kg
Number of subjects: 20
Study 8409060 — intervention group
Group type: EXPERIMENTAL
Intervention: Albunex 0.22 ml/kg
Number of subjects: 20
Study 2875235 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 min bicycling at 60-70% of maximum work capacity (Wmax) three times per week (3/week) for 4 weeks
Number of subjects: 13
Study 2875235 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 min bicycling seven times per week (7/week) for 4 weeks
Number of subjects: 13
Study 2875235 — intervention group
Group type: COMPARATOR
Intervention: Sedentary phase
Number of subjects: 13
Study 2875235 — intervention group
Group type: COMPARATOR
Intervention: Run-in phase
Number of subjects: 13
Study 29681200 — intervention group
Group type: EXPERIMENTAL
Intervention: plasma-derived factor VIII/von Willebrand factor (pdFVIII/VWF)
Number of subjects: 0
Study 29681200 — intervention group
Group type: COMPARATOR
Intervention: recombinant factor VIII (rFVIII)
Number of subjects: 0
Study 29681200 — intervention group
Group type: COMPARATOR
Intervention: Comparison of pdFVIII/VWF vs rFVIII
Number of subjects: 0
Study 26522081 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Ca group (40 g of milk powder containing 300 mg of Ca and 5 μg of vitamin D)
Number of subjects: 150
Study 26522081 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-Ca group (same milk powder additionally fortified with 300 mg of Ca)
Number of subjects: 150
Study 26522081 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Ca group (same milk powder additionally fortified with 600 mg of Ca)
Number of subjects: 150
Study 24118636 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis E vaccine Hecolin(®)
Number of subjects: 12409
Study 24118636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12409
Study 24118636 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-existing immunity
Number of subjects: 12409
Study 23019349 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency thermal ablation (RTA)
Number of subjects: 40
Study 23019349 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 40
Study 23019349 — intervention group
Group type: EXPERIMENTAL
Intervention: RTA in patients with toxic TNs
Number of subjects: 40
Study 20159379 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrarapid IV hydration (50 mL/kg normal saline for 1 hour)
Number of subjects: 88
Study 20159379 — intervention group
Group type: COMPARATOR
Intervention: Standard IV hydration (50 mL/kg normal saline for 3 hours)
Number of subjects: 88
Study 20159379 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrarapid IV hydration
Number of subjects: 88
Study 20159379 — intervention group
Group type: COMPARATOR
Intervention: Standard IV hydration
Number of subjects: 88
Study 17654232 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant-supplemented group (500 mg/day of vitamin E, 30 mg/day of beta-carotene, and for the last 15 days, 1 g/day of vitamin C)
Number of subjects: 15
Study 17654232 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant-supplemented group
Number of subjects: 15
Study 17654232 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 15
Study 17654232 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 15
Study 15984138 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-stage dental health promotion programme
Number of subjects: 0
Study 11999627 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin
Number of subjects: 24
Study 11999627 — intervention group
Group type: COMPARATOR
Intervention: Control (other AEDs)
Number of subjects: 24
Study 10412891 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg E2 tablets
Number of subjects: 18
Study 10412891 — intervention group
Group type: COMPARATOR
Intervention: 2 mg E2V tablets
Number of subjects: 18
Study 10412891 — intervention group
Group type: COMPARATOR
Intervention: 1.5 mg E2 plus 0.15 mg DSG tablets
Number of subjects: 18
Study 7751882 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-drugs-in-1-day chemotherapy without RT
Number of subjects: 25
Study 7751882 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniospinal RT and chemotherapy (vincristine, lomustine (CCNU), and prednisone)
Number of subjects: 25
Study 7751882 — intervention group
Group type: COMPARATOR
Intervention: Craniospinal RT
Number of subjects: 25
Study 2268023 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 and 22 gauge cannulae
Number of subjects: 80
Study 2268023 — intervention group
Group type: EXPERIMENTAL
Intervention: 22 gauge Jelco cannulae
Number of subjects: 80
Study 388396 — intervention group
Group type: EXPERIMENTAL
Intervention: Tienilic acid 250 mg/day
Number of subjects: 16
Study 388396 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg b.d.
Number of subjects: 16
Study 388396 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of tienilic acid 250 mg/day and propranolol 80 mg b.d.
Number of subjects: 16
Study 388396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 388396 — intervention group
Group type: EXPERIMENTAL
Intervention: Tienilic acid
Number of subjects: 16
Study 30635070 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (six cycles of capecitabine and oxaliplatin)
Number of subjects: 14
Study 30635070 — intervention group
Group type: COMPARATOR
Intervention: Historic control group (postoperative adjuvant chemotherapy)
Number of subjects: 14
Study 29264988 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 35
Study 25819007 — intervention group
Group type: EXPERIMENTAL
Intervention: Four doses of unpegylated filgrastim (87.5%)
Number of subjects: 51
Study 25819007 — intervention group
Group type: COMPARATOR
Intervention: Pegylated filgrastim once per cycle (89.4%)
Number of subjects: 51
Study 25819007 — intervention group
Group type: EXPERIMENTAL
Intervention: Four doses of unpegylated filgrastim
Number of subjects: 51
Study 25819007 — intervention group
Group type: COMPARATOR
Intervention: Pegylated filgrastim once per cycle
Number of subjects: 51
Study 23955812 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9 rs2250889 PR/RR genotype in the training cohort
Number of subjects: 421
Study 23955812 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9 rs17576 RQ/QQ genotype in the training cohort
Number of subjects: 421
Study 23955812 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9 rs2250889 genotype in the validation cohort
Number of subjects: 421
Study 23955812 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9 rs17576 genotype in the validation cohort
Number of subjects: 421
Study 23955812 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9 rs17576 genotype in multivariate analysis
Number of subjects: 421
Study 22211211 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based advanced practice nurse (APN) intervention (PATH) with a minimum of one visit per week for one year
Number of subjects: 238
Study 22211211 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 238
Study 19363909 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobetasol propionate shampoo 0.05%
Number of subjects: 0
Study 17389757 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptide inhalation
Number of subjects: 24
Study 17389757 — intervention group
Group type: COMPARATOR
Intervention: Diluent
Number of subjects: 24
Study 15179062 — intervention group
Group type: EXPERIMENTAL
Intervention: Blindfolding for 5 consecutive days (96 hours)
Number of subjects: 13
Study 11487742 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (345 mg/d)
Number of subjects: 63
Study 11487742 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 9726699 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg daily for 5 days
Number of subjects: 12
Study 9726699 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7520257 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous ventilation (Group 1)
Number of subjects: 40
Study 7520257 — intervention group
Group type: COMPARATOR
Intervention: Controlled ventilation to an initial PETCO2 of 3 kPa (22 mmHg) (Group 2)
Number of subjects: 40